Managing neoplastic bone disease with ibandronic acid: a preclinical and clinical data update
May 2012
Authors : Martin Pecherstorfer
Affliation : Hematologic-Oncologic Service, Landeklinikum Krems, Mitterweg 10, A-3500 Krems, Austria ; ; martin.pecherstorfer@krems.lknoe.at
DOI : 10.1517/14656566.0.0.348462
Published in : Expert Opin. Pharmacother.
Subject:
Keywords: bisphosphonates , bone metastases , breast cancer , efficacy , ibandronic acid , intravenous , oral , safety